Research Areas

  • Cancer Health Outcomes
  • Health Disparities
  • Mental Health
  • Health-related Quality of Life

Scientific Achievements

  • Examined cancer outcomes (colorectal, breast) by race and insurance.
  • Informed decision making in health care at the individual, community, and policy levels.
  • Worked with various complex datasets to study disease outcomes ranging from mental illnesses to various other chronic conditions.
  • Assessed community respondents’ willingness, attitudes, and beliefs (vaccine hesitancy) toward clinical trials participation.

Funding

RCMI Funding:

  • U54 MD007582, NIH/NIMHD

Other funding obtained with RCMI support:

  • FDA: 1U01FD007571-01
  • FLDOH: 007561-DOH COVID-19

Scientific Advance

Associations of Content and Context of Communication with Prostate-Specific Antigen Testing
Published in Journal of Environmental Research and Public Health (IJERPH), Volume 20, 2023, PMCIDP: PMC 10177781.
This study sought to understand how physician-patient communication influenced prostate-specific antigen (PSA) testing. We used data from the Florida Behavioral Risk Factor Surveillance System. Receipt of PSA testing was examined as a function of content (patient-physician discussions of risks and benefits of PSA testing, provider recommendations of PSA testing) and context of communication (presence of a personal doctor) after accounting for sociodemographic, clinical, healthcare access, and lifestyle characteristics. Men who engaged in conversations with their physician, who were given recommendations for PSA testing by their providers, and who benefitted from the continuity of care denoted by the presence of a personal doctor had a greater likelihood of PSA receipt than those who did not experience these elements of patient-centered care.
NIH/NIMHD #U54MD007582
Toggle Navigation